It has been proven that the expression of Fyn in glioma patients is closely related to EGFR, and Fyn is a direct effector molecule of carcinogenic EGFR and significantly promotes the invasion of glioma cells with high expression of EGFR22. This evidence concerns the gene EGFR and central nervous system cancer.